Cogent Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cogent Biosciences announces its 2026 Annual Meeting of Stockholders to be held virtually on June 9, 2026.
NASDAQ
Cogent Biosciences has scheduled its Annual Meeting of Stockholders for June 4, 2025, and is seeking votes on director elections, auditor ratification, executive compensation, and an amendment to the company's Certificate of Incorporation.
NASDAQ
Cogent Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on June 4, 2025, including proposals for director elections, auditor ratification, executive compensation advisory vote, and an amendment for officer exculpation.
NASDAQ
DEFA14A: Cogent Biosciences Sets Date for Annual Meeting, Seeks Stockholder Approval on Key Proposals
Cogent Biosciences has scheduled its Annual Meeting for June 5, 2024, where stockholders will vote on director elections, auditor ratification, executive compensation, and an increase in authorized common stock.
NASDAQ
Cogent Biosciences is holding its 2024 Annual Meeting of Stockholders on June 5, 2024, to vote on key proposals including director elections, ratification of auditors, executive compensation, and an increase in authorized common stock.